Medirom Healthcare Technologies Inc

Aktienanalyse zu Medirom Healthcare Technologies Inc (MRM)

$0.950

+0.010 (+1.06%)Zum Schluss

Loading chart…
High
0.990
Open
0.930
VWAP
0.95
Vol
21.87K
Mkt Cap
18.55M
Low
0.910
Amount
20.77K
EV/EBITDA, TTM
0.00

Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices.

medirom.co.jp

AI analysis of Medirom Healthcare Technologies Inc (MRM)

hold

Currently, MRM is not a strong buy due to its low price and negative performance indicators. The stock is priced at $0.95, down 51.53% year-to-date, indicating significant downward pressure. Additionally, the RSI is at 37.334, suggesting that the stock is nearing oversold territory but has not yet reversed. The forward P/E ratio is 0, indicating no expected earnings growth, which is concerning. The main risk is its significant year-to-date decline of 51.53%, which could indicate ongoing challenges.

Bewertungskennzahlen

The current forward P/E ratio for Medirom Healthcare Technologies Inc (MRM) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
2.62
Current EV/EBITDA
0.00
Überbewertet
7.70
Unterbewertet
-2.46

Forward P/S

Fair
5Y Average P/S
0.04
Current P/S
0.00
Überbewertet
0.13
Unterbewertet
-0.05

Alphio AI Price Scenarios for MRM

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%MRM

$1.40

Szenariopreis

B

Base

Base · 50%MRM

$1.32

Szenariopreis

B

Bear

Bear · 25%MRM

$1.07

Szenariopreis

Event-Zeitleiste

2026-02-27 (ET)

08:10:00

Medirom Healthcare Signs Agreement with Tools for Humanity, Projects $39 Million Income Over Two Years

2025-12-29 (ET)

08:30:00

MEDIROM Collaborates with World Foundation to Deploy Proof of Human Technology in Japan

2025-12-26 (ET)

18:00:00

Medirom Healthcare Partners with World Foundation to Deploy Proof of Human Technology

2025-10-29 (ET)

10:25:23

Medirom Healthcare to Introduce New Treasury Strategy Utilizing Cryptocurrency

2025-10-28 (ET)

08:36:02

Medirom Healthcare reports that more than 10,000 individuals have obtained World IDs at various locations.

News

MRM FAQ — answered by Alphio AI

Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices. It operates in the Consumer Non-Cyclicals sector.

Currently, MRM is not a strong buy due to its low price and negative performance indicators. The stock is priced at $0.95, down 51.53% year-to-date, indicating significant downward pressure. Additionally, the RSI is at 37.334, suggesting that the stock is nearing oversold territory but has not yet reversed. The forward P/E ratio is 0, indicating no expected earnings growth, which is concerning. The main risk is its significant year-to-date decline of 51.53%, which could indicate ongoing challenges.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten